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At the interface between T cell and antigen-presenting cell (APC), peptide antigen presented by MHC (pMHC) binds to
the T cell receptor (TCR) and initiates signaling. The mechanism of TCR signal initiation, or triggering, remains unclear.
An interesting aspect of this puzzle is that although soluble agonist pMHCs cannot trigger TCR even at high
concentrations, the same ligands trigger TCR very efficiently on the surface of APCs. Here, using lipid bilayers or
plastic-based artificial APCs with defined components, we identify the critical APC-associated factors that confer
agonist pMHCs with such potency. We found that CD4
þT cells are triggered by very low numbers of monomeric agonist
pMHCs anchored on fluid lipid bilayers or fixed plastic surfaces, in the absence of any other APC surface molecules.
Importantly, on bilayers, plastic surfaces, or real APCs, endogenous pMHCs did not enhance TCR triggering. TCR
triggering, however, critically depended upon the adhesiveness of the surface and an intact T cell actin cytoskeleton.
Based on these observations, we propose the receptor deformation model of TCR triggering to explain the remarkable
sensitivity and specificity of TCR triggering.
Citation: Ma Z, Sharp KA, Janmey PA, Finkel TH (2008) Surface-anchored monomeric agonist pMHCs alone trigger TCR with high sensitivity. PLoS Biol 6(2): e43. doi:10.1371/
journal.pbio.0060043
Introduction
Using T cell receptors (TCRs) as sensors, T cells probe the
surface of antigen-presenting cells (APCs) for the presence of
antigenic (agonist) peptides presented by major histocompat-
ibility complex (pMHC) molecules. Engagement of TCRs by
agonist pMHCs initiates a signal, which is transmitted to the
nucleus via kinase cascades and protein translocation,
leading, ultimately, to T cell activation. In clear contrast to
advances in our understanding of intracellular TCR signaling
pathways, the question of how binding of pMHC initiates or
triggers TCR signaling remains unclear [1]. This is despite
knowledge gained from the study of triggering mechanisms of
other receptor systems, for example, the conformational
change of G protein-coupled receptors and the dimerization
of growth factor receptors. The difﬁculty in resolving the
mechanism of TCR triggering is attributed to the complexity
of multichain TCR/CD3 structure, the diversity of peptides
presented by MHCs on APCs, and importantly, the complex
environment where pMHC-TCR interaction takes place.
One fundamental question still unanswered is the mini-
mum requirements for TCR triggering. In terms of the pMHC
ligand, a critical question is whether a monomeric agonist
pMHC alone can trigger TCR independently, or whether it
must act cooperatively with another neighboring pMHC,
either agonist or endogenous, as a dimer to simultaneously
engage, and in effect crosslink, two TCRs. In terms of the
environment or the context of TCR triggering, critical
questions are whether soluble agonist pMHCs are capable
of triggering TCR or if they must be surface-anchored,
whether molecules other than pMHCs on APCs, e.g.,
costimulatory molecules, contribute to TCR triggering, and
whether and how physical and mechanical aspects of the T
cell–APC interaction play a role in TCR triggering. There are
reports showing that TCR is no different from receptors for
soluble ligands, e.g., hormone receptors, and that soluble
monomeric pMHCs are sufﬁcient to trigger TCR [2–4]. These
data suggested that TCR must be triggered through either
TCR conformational change or heterodimerization of TCR
and CD4 or CD8 coreceptor via simultaneous pMHC binding.
In these studies, however, binding of peptides [5] or pMHC
molecules to the surface of the cell or culture dish was
difﬁcult to rule out. Mechanistically, with one exception [6],
rather extensive crystallography studies have not revealed
global large-scale conformational changes of TCR after
engagement of agonistic pMHCs [7–14]. It is also uncertain
whether coreceptors play a role in TCR triggering, since TCR
triggering in vitro and in vivo [15,16] can occur in the
complete absence of CD4 or CD8. Moreover, these studies are
contradicted by data showing the total lack of TCR triggering
capability of soluble agonist pMHCs in solution even at very
high concentrations [17–22]. In sharp contrast, however,
many studies have demonstrated the remarkable potency of a
few agonist pMHCs on APCs to trigger TCR [23–25]. If TCR
triggering by agonist pMHCs depends upon the context of
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PLoS BIOLOGYthe APC, then the question becomes what else at the interface
of T cell–APC interaction contributes to TCR triggering.
Based upon observations of T cell activation by antibody
crosslinking, TCR crosslinking by agonist–agonist pMHCs has
been proposed as the mechanism of TCR triggering. This
theory relies upon the presence of putative agonist–agonist
pMHCs on the APC surface, and is supported by observations
that a signiﬁcant fraction of MHCs on APCs are immobile
[26,27]; thus, two agonist pMHC monomers could act as a
dimer if they are immobilized close to each other. However,
since TCR can be triggered by only a few agonist pMHCs
amongst a huge number of endogenous pMHCs on the APC,
the chance of agonist–agonist pMHC formation should be
very small. Getting around this issue is a recent theory that
TCR is triggered by a ‘‘pseudodimer’’ of an agonist pMHC
and an endogenous pMHC [28,29], based upon data showing
that some endogenous pMHCs enhance TCR triggering by
agonist pMHCs. In addition to the possible contribution of
endogenous pMHCs on APCs, van der Merwe and colleagues
have postulated that the two-dimensional (2D) nature of the
pMHC–TCR interaction plays a critical role in triggering. The
proposed kinetic-segregation model [30–32] suggests that
TCR signal initiation is induced by segregation of small
kinase-associating molecules and large phosphatase-associat-
ing molecules at the tight junction between a T cell and an
APC, leading to a net increase in tyrosine kinase activity
proximate to the TCR/CD3 complex. This model would
obviate the need for receptor crosslinking and require only
monomeric agonist pMHC.
With conﬂicting data and the multiple models proposed, it
is clear that there is no consensus regarding the mechanism
of TCR triggering. A solution to this puzzle would be aided by
deﬁnition of the critical factors involved in the T cell–APC
interaction that directly contribute to TCR triggering by
agonist pMHCs. Here, we test TCR triggering using artiﬁcial
APCs consisting of ﬂuid lipid bilayers or ﬁxed plastic surfaces
with deﬁned components. We demonstrate that TCR can be
triggered by a very low number (1–10) of monomeric agonist
pMHCs. TCR triggering is independent of endogenous
pMHCs and of any other molecule found on real APC
surfaces, but is critically dependent upon (1) surface-anchor-
ing of pMHC, (2) T cell adhesion to the surface, and (3) intact
actin cytoskeletal function. Based upon these data, and
incorporating the impact of mechanical stress on pMHC-
TCR binding kinetics, we propose the receptor deformation
model of TCR triggering by monomeric pMHCs on a surface.
In this model, TCR is triggered by TCR/CD3 conformational
changes induced by a cytoskeletal pulling force, transferred
via speciﬁc pMHC-TCR interactions with sufﬁcient resistance
to rupture under force.
Results
Establishment of a Lipid Bilayer-Based Artificial APC
System
To anchor pMHCs on a ﬂuid surface, we developed a
planar lipid bilayer-based artiﬁcial APC (Figure 1A). This
consisted of a glass-supported lipid bilayer anchored with
pMHC and ICAM-1, via interactions between nitrilo triacetic
acid-Ni (NTA-Ni) lipid head groups on the bilayer and 63
histidine (HisTag) at the membrane-proximal ends of the
proteins. An initial consideration was that artiﬁcial pMHC
dimers may be formed by monomers immobilized in close
proximity on lipid bilayers with defects in ﬂuidity or
homogeneity. Avoidance of such de facto dimer formation
was crucial for interpretation of our experimental data. To
this end, a novel technique of lipid bilayer expansion was
employed to achieve a higher level of large-scale lipid bilayer
homogeneity and ﬂuidity compared to previously reported
methods. The newly expanded area of lipid bilayer showed
excellent homogeneity and stability in buffer containing
bovine serum albumin (BSA), with no defects visible by
ﬂuorescence microscopy (Figure 1B). As expected, given its
genesis by lipid translocation, the newly expanded lipid
bilayer showed a high level of ﬂuorescence recovery after
photobleaching (FRAP) of a spot of 4-lm radius, indicating a
mobile fraction of close to 100% and a calculated diffusion
coefﬁcient of approximately 0.8 lm
2/sec (Figure 1C), in
agreement with typical lipid diffusion rates in biological
membranes [33]. The lipids diffuse freely over long range as
shown in the recovery of a larger bleaching spot (Figure S1A).
Only this newly expanded area of lipid bilayer was used for
interaction with T cells. To anchor monomeric pMHC on the
bilayer, a lipid with an NTA head group (DOGS-NTA) was
doped in the bilayer at 5 mol% and charged with Ni
2þ to
allow binding of soluble ligands with HisTags.
To generate soluble monomeric pMHCs, extracellular
domains of MHC class II IEk molecules, each with one of
three different covalently linked peptides, were expressed as
secreted forms using a baculovirus system in insect cells [34]:
IEk-MCC (agonist peptide moth cytochrome c residues 88–
103) [35], IEk-HSP70 (endogenous peptide HSP70 234–248)
[29,36], and IEk-ER60 (endogenous peptide ER60 448–461)
[29,37]. IEk-MCC is a well-characterized ligand for the
Va11Vb3 TCR expressed on CD4
þ T cells from the TCR
transgenic mice AD10, AND, and 5C.C7 [38–40]. All IEk
proteins were engineered to have an AviTag sequence
followed by a HisTag sequence connected to the mem-
brane-proximal ends of the b chain via ﬂexible linkers. The
AviTag sequence allows biotinylation of a single lysine
residue by the BirA enzyme. All proteins displayed the same
single peak corresponding to approximately 50 kDa in gel
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Author Summary
Using the T cell receptor (TCR) as a sensor, T cells of the immune
system constantly migrate in lymphoid organs and probe the
surface of antigen-presenting cells (APCs) for foreign antigens, a sign
of pathogen infection. Antigen binding by TCRs leads to T cell
activation and subsequent immune response to combat the
pathogens. Interestingly, although T cells respond well to antigens
on APCs, they do not recognize the same antigens in solution. What
is it that makes antigens on APCs recognizable? To address this, we
used lipid bilayers and plastic surfaces to construct artificial APCs
with defined antigen number, composition, and configuration. We
found that T cells respond to very few individual foreign antigens on
artificial APCs, and contrary to some current opinion, formation of
antigen clusters on APCs is not required for antigen recognition by T
cells. TCR triggering, however, requires T cell adhesion to the APC
surface and then occurs only if the T cells are able to move. We
propose that at the dynamic T cell–APC interface, antigen on APCs
activates T cells by applying force to the TCR and deforming its
structure, which cannot be achieved by soluble antigens due to
their lack of anchorage.ﬁltration chromatography (Figure S2A). Their secondary
structures were conﬁrmed by circular dichroism spectra
(Figure S2B) and thermal melting proﬁles (Figure S2C), both
of which are consistent with that of IEk with bound MCC
peptide, described previously [41]. In particular, all three
proteins showed similar thermal melting proﬁles with sharp
transitions at high temperature (Tm¼;72 8C), indicating that
the protein structures are stabilized by bound peptides, since
empty IEk without peptide melts at a much lower temper-
ature and with a broad transition [41]. As expected, when
immobilized on ELISA plates, only agonist IEk-MCC induced
interleukin 2 (IL2) production by primed AD10 T cells
(Figure 1D). Moreover, incubation of the endogenous pep-
tide-IEk proteins (IEk-ER60 or IEk-HSP70) with MCC
peptides under conditions reported to load 80% of empty
IEks [42] did not endow them with T cell activation capacity
(Figure S2D). These data indicate that all three IEk proteins
were properly folded with their peptide-binding grooves
occupied.
Afﬁnity puriﬁed IEk proteins were monomers as shown by
gel ﬁltration chromatography (Figure S2A), and did not
trigger TCR in solution (unpublished data), consistent with
previous reports [17–22]. IEk-MCC proteins were never
subjected to freezing and thawing, and were always further
puriﬁed by gel ﬁltration immediately before use. When
anchored on the lipid bilayer through HisTag-Ni-NTA
binding, IEk proteins moved freely with a diffusion rate only
slightly slower than that of the lipids (Figure S1B). The density
of IEk on the bilayer was measured at about 2,900 per lm
2.
GFP-HisTag and ICAM-1-HisTag were also expressed in
insect cells for use as a control and in enhancement of T
cell adhesion, respectively. Thus, we had in hand a lipid
bilayer-based artiﬁcial APC system, consisting of a lipid
bilayer and proteins with the requisite qualities for study of T
cell/APC interactions.
Fewer than Ten Monomeric Agonist pMHCs Are Sufficient
to Trigger TCR
To test the ability of agonist pMHCs alone on a ﬂuid
surface to trigger TCR, IEk-MCC was mixed with GFP-HisTag
at varying ratios prior to anchoring on the lipid bilayer while
maintaining a constant concentration of total protein. ICAM-
1-HisTag was added at a concentration equal to one-tenth of
the total protein concentration. After contacting lipid
bilayers with bound IEk-MCC, primed AD10 T cells demon-
strated rapid increases in intracellular calcium, as indicated
by an increase in the 340 nm/380 nm ratio (Figure 2A and
Video S1). Both the percentage of responding T cells and the
amplitude of the increase in intracellular calcium were
clearly dependent on the dose of agonist IEk-MCC (Figure
2B and 2C). A 340 nm/380 nm ratio two times above
background was observed in T cells interacting with a bilayer
anchored with IEk at a GFP:IEk-MCC ratio of up to 100,000:1,
whereas no increase in 340 nm/380 nm ratio was observed in
T cells interacting with bilayers anchored with only GFP
(Figure 2A and 2C, and Video S2). On the basis of the
measured size of primed mouse CD4
þ T cells and the density
of IEk on the lipid bilayer, we calculated that, on average,
three agonist IEk-MCC monomers were sufﬁcient to trigger a
low-level calcium response in about 5% of T cells. The same
Figure 1. Characterization of the Protein and Lipid Bilayer Components of Artificial APCs
(A) Schematic of the interaction between the T cell and the NTA-Ni lipid bilayer-based artificial APC.
(B) The expanded area of the POPC bilayer doped with 0.2 mol% fluorescent DOPE-NBD (green). The scale bar represents 10 lm.
(C) Fluorescence recovery of a photobleached area (r ¼ 4 lm) on the POPC/1mol% DOPE-NBD bilayer.
(D) Immobilized agonist, but not endogenous pMHC, stimulates AD10 T cells to produce IL2. The 96-well ELISA plates were coated with IEk proteins at
the indicated concentrations. AD10 CD4
þ T cells were assayed for IL2 production.
doi:10.1371/journal.pbio.0060043.g001
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MCC was anchored on the bilayer alone (Figure 2B).
To test whether TCR triggering is inﬂuenced by the ﬂuidity
of the pMHC anchoring surface, we immobilized IEk
molecules on a ﬁxed plastic surface. IEk molecules biotiny-
lated on the AviTag sequences were diluted and immobilized
on 96-well plates precoated with streptavidin for 18 h at 37 8C
for thorough binding. Bio-IEk-MCC–coated wells stimulated
AD10 T cells to produce IL-2 in a dose-dependent manner
(Figure 3A). Approximately 5% of the T cells were activated
by a surface coated with bio-IEk-MCC diluted to a concen-
tration of 1.9 3 10
 6 lg/ml. Assuming that all bio-IEk-MCC
molecules bound to the surface of the well, and using 78.5
lm
2 as the T cell contact area based on the measured
diameter of primed T cells, we calculated that 0.83 bio-IEk-
MCC molecules per cell, or 83 bio-IEk-MCC per 100 cells,
were sufﬁcient for T cell activation. In contrast, surfaces
coated with bio-IEk-ER60, bio-IEk-HSP70, or bio-IEk-99A did
not activate AD10 T cells even at the highest coating
concentration, although they bound comparably to strepta-
vidin-coated wells (Figure 3B). IEk-99A contains a covalently
linked MCC peptide with a single K.A mutation at the p5
Figure 2. Very Low Numbers of Monomeric Agonist IEk Anchored on a Lipid Bilayer Are Sufficient to Trigger T Cell Calcium Flux, Independent of
Endogenous IEk
(A) IEk-MCC mixed with GFP-HisTag, IEk-ER60, or IEk-HSP70 at the indicated ratios was anchored on a lipid bilayer containing 5 mol% DOGS-NTA-Ni.
Increase in the intracellular calcium level in AD10 TCR transgenic CD4
þT cells labeled with fura-2 is indicated by an increase of the 340 nm/380 nm ratio
in the pseudocolor images. Bilayers with GFP-HisTag or endogenous IEk only, without IEk-MCC, served as controls.
(B) Percentage of AD10 T cells with at least two times increased intracellular calcium levels in response to IEk-MCC alone or mixed with GFP-HisTag, IEk-
ER60, or IEk-HSP70 on NTA-Ni lipid bilayers at the indicated ratios.
(C) Same as (B), except that the average peak calcium level is shown as the 340 nm/380 nm ratio. The 340 nm/380 nm ratios of T cells stimulated with
‘‘No MCC’’ are average ratios of T cells interacting with lipid bilayers anchored with only GFP-HisTag or endogenous IEks.
(D) Change in AD10 T cell intracellular calcium levels over time after contacting NTA-Ni bilayers anchored with IEk-MCC mixed with IEk-ER60 or IEk-
HSP70 at a 1:1,000 ratio. Data were compiled from 17 AD10 T cells in each group.
doi:10.1371/journal.pbio.0060043.g002
PLoS Biology | www.plosbiology.org February 2008 | Volume 6 | Issue 2 | e43 0331
pMHC Surface Anchoring & TCR TriggeringFigure 3. Very Low Numbers of Agonist IEk Anchored on a Fixed Surface Induce AD10 T Cell IL2 Production, Independent of Endogenous or Null IEk,
or IAk
(A) Bio-IEk-MCC, bio-IEk-ER60, bio-IEk-HSP70, or bio-IEk-99A at the indicated concentrations were added to 96-well plates precoated with streptavidin
and incubated for 18 h at 37 8C. AD10 CD4
þ T cells were added to the wells and stimulated for 7 h prior to IL2 assay.
(B) The level of IEk proteins on streptavidin plates coated as in (A) was determined by ELISA using anti-IEk 14-4-4s antibody followed by HRP-conjugated
goat anti-mouse antibody. ABTS substrate color development was monitored at 405 nm.
(C) Streptavidin plates coated with bio-IEk-MCC at the indicated concentrations were subsequently saturated with 10 lg/ml bio-IEk-ER60, bio-IEk-
HSP70, bio-IEk-99A, or buffer for 1 h at room temperature before being used to stimulate AD10 T cells.
(D) The 96-well ELISA plates were coated with bio-IEk-MCC at the indicated concentrations overnight at 4 8C. The wells were then saturated with 10 lg/
ml BSA, IEk-ER60, IEk-HSP70, IEk-99A, or IAk-CA for 4 h at room temperature. Stimulation of AD10 and measurement of IL2 measurements were done as
described in (A).
(E and F) Same as (C) and (D), respectively, except that 5C.C7 cells were used.
doi:10.1371/journal.pbio.0060043.g003
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5C.C7 T cells [43,44]. Thus, T cell activation is induced by very
low numbers of agonist, but not endogenous or null, pMHC
when presented to T cells on either a ﬂuid or a ﬁxed surface.
TCR Triggering by Agonist pMHCs Is Independent of
Endogenous pMHCs
The conventional notion of TCR crosslinking is by two
agonist pMHCs. Because of the very low number of agonist
IEk needed to trigger TCR and the highly ﬂuid nature of the
lipid bilayer, it was unlikely that agonist–agonist IEk dimers
were present on the lipid bilayer. It has been reported,
however, that endogenous pMHCs dramatically enhance TCR
triggering by agonist pMHCs by formation of ‘‘pseudo-
dimers’’ [28,29]. To determine the role of endogenous pMHC
in TCR triggering, we replaced GFP-HisTag with IEk-ER60 or
IEk-HSP70. AD10 T cells responded similarly to IEk-MCC in
the context of IEk-ER60 or IEk-HSP70, as well as to IEk-MCC
in the context of GFP (Figure 2A–2C and Videos S1, S3, and
S4), both in terms of the percentage of responding T cells and
the level of calcium increase. Similar results were found using
primed 5C.C7 T cells (unpublished data). In addition, we did
not observe any difference between IEk-MCC diluted with
IEk-HSP70 or with IEk-ER60 in triggered T cell calcium ﬂux
patterns (Figure 2D). This is in contrast to a previous report
in which only IEk-ER60, but not IEk-HSP70, worked
synergistically with IEk-MCC, reportedly through pseudo-
dimer formation [29].
To facilitate the formation of pseudodimers between IEk-
MCC and endogenous IEks, we immobilized bio-IEk-MCC of
varying dilutions onto streptavidin-coated 96-well plates. This
was followed by incubation with coating buffer, bio-IEk-ER60,
bio-IEk-HSP70, or bio-IEk-99A at an experimentally con-
ﬁrmed saturating concentration to occupy remaining free
biotin binding sites. We reasoned that binding of bio-IEk-
MCC and endogenous pMHC on the same tetravalent
streptavidin molecule under these conditions would form
stably linked pseudodimers. The distance between pMHCs,
but not their orientation, is reportedly important for TCR
crosslinking [45], with comparable crosslinking demonstrated
for linkers ranging from a direct disulﬁde bond (0.2 nm) to a
peptide crosslinker of 7 nm in length [45]. The distance
between two biotin binding sites (;3 nm) on streptavidin is
well within this range [46]. Indeed, streptavidin bound with
two or more IEk-MCC is capable of activating T cells in
solution [22]. Consistent with our observed calcium responses
to IEk on lipid bilayers, saturating the surface with
endogenous bio-IEk-ER60, bio-IEk-HSP70, or bio-IEk-99A
did not enhance the ability of bio-IEk-MCC to induce IL2
production by AD10 T cells (Figure 3C) or 5C.C7 cells (Figure
3E). These results were conﬁrmed by experiments showing
that activation of AD10 T cells (Figure 3D) or 5C.C7 T cells
(Figure 3F) by bio-IEk-MCC directly bound to ELISA plates
was not enhanced by subsequent saturation binding by IEk-
ER60, IEk-HSP70, IEk-99A, or IAk-CA. IAk coexists with IEk
on the same APCs in vivo. IAk with covalently linked
conalbumin peptide (IAk-CA) activates T cells bearing D10
TCRs (Figure S3). On the ELISA plate, the density of bio-IEk-
MCC remained the same with or without subsequent
saturation binding by other proteins (Figure S4). The differ-
ence in shape and range of the response curves to IEk on
streptavidin versus ELISA plates is likely a result of their
different surface properties (see Text S1). Therefore, on ﬂuid
lipid bilayers or on ﬁxed surfaces, T cell activation induced by
agonist IEk-MCC was not enhanced by endogenous IEk, null
IEk, or another MHC class II molecule, IAk.
Skewing Endogenous Peptide Populations on a Real APC
Surface Does Not Affect T Cell Activation by Agonist
Peptides
To test the role of endogenous pMHCs in TCR triggering
under more physiologic conditions, we skewed the makeup of
endogenous peptides on real APCs. We wished to determine
whether the ability of APCs to activate T cells could be
altered by replacing a major proportion of the original
diverse endogenous peptide population with a peptide having
putative enhancing or nonenhancing effects on TCR trigger-
ing. Murine B-cell lymphoma CH27 cells expressing IEk were
incubated with biotinylated b2m peptides (b2m-bio), ER60
peptides (ER60-bio), or scrambled ER60 peptides (ER60scrbl-
bio) at high concentrations for 20 h. To determine the degree
of IEk occupancy by the biotinylated peptides, pulsed cells
were stained with streptavidin-Cy5, and the ﬂuorescence
intensity was compared with CH27 cells stained with
biotinylated anti-IEk monoclonal antibody, 14-4-4s (14-4-4s-
bio), followed by streptavidin-Cy5. The peptides were
biotinylated at the N-terminus, so each peptide bound to
one streptavidin-Cy5. The number of streptavidin-Cy5 each
14-4-4s-bio antibody could bind was determined using a gel
ﬁltration chromatography-based assay (Figure S5), and the
result was used to correct for differences in ﬂuorescence
intensity. Using this assay, we determined that b2m-bio,
ER60-bio, or ER60scrbl-bio peptides occupied about 59%,
17%, or 3%, respectively, of IEk molecules on the surface of
CH27 cells (Figure S6). The peptide binding was IEk-speciﬁc;
only a very low level of binding was observed on the mutant
murine B-cell lymphoma, M12.C3, which is deﬁcient for MHC
class II (Figure S6). The CH27 cells were then brieﬂy
incubated with FITC-labeled MCC peptides (MCC-FITC)
before adding to a T cell stimulation assay. MCC-FITC
pulsing led to comparable FITC levels on CH27 cells
prepulsed with b2m-bio, ER60-bio, or ER60scrbl-bio (Figure
4A), while maintaining relatively consistent IEk occupancy by
biotinylated endogenous peptides (unpublished data). In a
previous report, only ER60, but not b2m, enhanced T cell
activation, presumably by forming pseudodimers with agonist
pMHC [29]. If this were the case, then skewing the
endogenous peptide population on the CH27 surface towards
ER60 or b2m should signiﬁcantly enhance or reduce,
respectively, the chance of pseudodimer formation, and lead
to different degrees of T cell activation upon stimulation by
comparable levels of agonist MCC peptides. In contrast, in
our hands, T cells stimulated with CH27 cells prepulsed with
either ER60-bio or b2m-bio showed very similar IL2
production to cells prepulsed with the control ER60scrbl-
bio peptide (Figure 4B), a peptide which did not signiﬁcantly
alter the original endogenous peptide makeup. Therefore, on
real APCs, agonist pMHCs appear to operate independently
of endogenous pMHCs in T cell stimulation.
TCR Triggering by Agonist pMHCs on Lipid Bilayers
Requires T Cell Adhesion and Intact Cytoskeletal Function
Previous work [22] and our own experimental data argue
strongly that monomeric agonist pMHC cannot trigger TCR
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small number of agonist pMHCs, anchored on a surface, to
trigger TCR, we examined whether active adhesion was
required for triggering by our artiﬁcial APCs. T cells
spontaneously adhered to lipid bilayers containing NTA-Ni
(unpublished data), probably due to surface charge inter-
actions. The inability of this bilayer to become a nonadhesive
surface made it unsuitable for studies of the role of adhesion
in TCR triggering. Therefore, in order to have in hand a lipid
bilayer system with controllable adhesion properties, we
established a biotin-streptavidin–based artiﬁcial APC system
(Figure S7). Streptavidin molecules speciﬁcally bind to POPC
bilayers containing 5 mol% DOPE-biotin and diffuse freely
(Figure S1C). IEk and ICAM-1 molecules were biotinylated at
their AviTag sequences and mixed with streptavidin at ratios
suitable for forming complexes with desired valencies.
Monovalent (IEk-MCC)-streptavidin and divalent (ICAM-1)2-
streptavidin complexes were further puriﬁed by gel ﬁltration.
T cell adhesion to this bilayer was strongly dependent on the
presence of (ICAM-1)2-streptavidin on the bilayer (Videos S5
and S6). Bilayers anchored only with (IEk-MCC)-streptavidin
failed to stimulate AD10 T cell calcium ﬂux, even at relatively
high ligand densities (1,400/mm
2) (Figure 5A and Video S7). In
contrast, in the presence of ICAM-1, bilayers anchored with
(IEk-MCC)-streptavidin induced strong calcium ﬂux (Figure
5B and Video S8), suggesting that adhesion is required for
TCR triggering by agonist pMHC on the lipid bilayer.
In addition to adhesion, another important aspect of the
dynamic 2D interface formed by two highly mobile cells, such
as the T cell and its APC, is the impact of cytoskeletal
movement, which may directly apply force upon pMHC-TCR
binding. To test the role of the actin cytoskeleton in TCR
triggering by agonist pMHC, AD10 T cells were treated with
the actin depolymerizing agent, cytochalasin D, before
interaction with a layer of CH27 cells pulsed with MCC
peptides on glass. While untreated AD10 T cells responded
with pronounced and sustained increases in intracellular
calcium (Figure 5C and Video S9), AD10 T cells pretreated
with cytochalasin D showed no response (Figure 5D and
Video S10), although in both cases, there was contact between
T cells and APCs (Figure S8). Similar results were observed
when T cells were stimulated with IEk-MCC anchored on ﬂuid
lipid bilayers or plastic surfaces (Figure S9). Therefore,
cytochalasin D treatment completely blunted T cell calcium
responses to real or artiﬁcial APCs. To test whether actin
cytoskeletal rearrangement is required for sustaining calcium
ﬂux that has already been initiated by real APCs, cytochalasin
D was introduced after the calcium ﬂux of untreated T cells
reached peak levels. In agreement with a previous report [47],
Figure 5. TCR Triggering by Monomeric Agonist pMHC Requires T Cell Adhesion to the Bilayer and Intact Actin Cytoskeletal Function
(A and B) Lipid bilayers containing 5 mol% DOPE-biotin were anchored with monovalent (IEk-MCC)-SA. The bilayers were then used to stimulate T cells
directly (A) or were further anchored with (ICAM-1)2-SA (B) before adding T cells. Bilayers anchored with only (ICAM-1-bio)2-SA did not induce T cell
calcium flux.
(C and D) A layer of CH27 cells pulsed for 1 h with 1 lM MCC-FITC was attached on cover glasses coated with poly-L-lysine. Fura-2 AM–pulsed AD10 T
cells treated with 10 lM cytochalasin D for 1 h (D), or untreated AD10 T cells (C) were introduced, and calcium flux was monitored.
(E) Similar to (C), except that 10 lM cytochalasin D (or DMSO as control) was introduced after T cell calcium flux reached peak levels.
doi:10.1371/journal.pbio.0060043.g005
Figure 4. On Real APCs, Endogenous Peptides Do Not Affect T Cell
Activation by Agonist Peptides
CH27 cells were cultured with 1 mM b2m-bio, ER60-bio, or ER60scrbl-bio
peptides for 20 h at 37 8C. After washing, cells were incubated with MCC-
FITC peptides at the indicated concentrations for 30 min before washing.
(A) The level of MCC-FITC on CH27 cells after pulsing, as measured by
flow cytometry.
(B) AD10 T cells were mixed with CH27 cells pulsed with MCC-FITC at the
indicated concentrations and IL2 production was measured by intra-
cellular staining after 7 h. Data are representative of three independent
experiments.
doi:10.1371/journal.pbio.0060043.g004
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Cytochalasin D treatment per se did not block events
downstream of TCR triggering leading to T cell calcium ﬂux,
since calcium ﬂux induced by anti-TCR antibody crosslinking
was unaffected (Videos S11–S13). Cytochalasin D treatment
also signiﬁcantly reduced T cell mobility and morphological
changes associated with interaction with CH27 cells (unpub-
lished data). Intact actin cytoskeletal function is therefore
required for TCR triggering by both artiﬁcial APCs and real
APCs.
Discussion
We demonstrate, using artiﬁcial APCs, that surface
anchoring, adhesion, and actin cytoskeleton enable mono-
meric agonist pMHCs to trigger TCR with remarkable
potency. T cells responded to an average of three and of
0.83 agonist pMHCs anchored on lipid bilayers and ﬁxed
plastic surfaces, respectively. Due to the nonaverage Poisson
distribution of the ligands on the surfaces, the responding T
cells might have contacted as many as seven and three agonist
pMHCs, respectively (see Text S2). Although it is possible that
T cells may have responded to a larger number of agonist
pMHCs on lipid bilayers due to their diffusion and
accumulation underneath T cells over time, the general
agreement between the required numbers of ligands on lipid
bilayers and plastic surfaces suggests that TCR can be
triggered by a very low number of agonist pMHCs anchored
on ﬂuid or ﬁxed surfaces.
We believe that an alternative interpretation of our data,
i.e., that TCR was triggered by agonist pMHC dimers, is
unlikely for the following reasons. First, we took great
caution in generating and purifying IEk-MCC proteins to
minimize the existence of dimers in our protein preparation.
The very low number of surface-anchored agonist pMHCs
required for TCR triggering (,10 per cell) (Figures 2A–2C,
3A, and Text S2) makes it highly unlikely that TCR was
triggered by dimer contamination in the protein prepara-
tion, which certainly did not contain .10% dimers (Figure
S2A). Second, to exclude the possibility of ‘‘de facto’’ dimer
formation by immobilization of two agonist pMHCs within
close proximity by chance, we developed the lipid bilayer-
based artiﬁcial APC system and went to great lengths to
ensure the homogeneity and ﬂuidity of the bilayer. Third,
although dimers might, theoretically, form spontaneously
between monomeric pMHCs diffusing freely on the bilayer,
the necessary intrinsic afﬁnity between MHC molecules is not
supported by experimental evidence. Despite the availability
of such highly sensitive techniques as surface plasmon
resonance, no quantitative measurement of afﬁnity between
MHC molecules has been documented, suggesting that the
afﬁnity between MHC molecules is extremely low, if there is
any. This is consistent with the fact that MHC-MHC dimers
have not been observed in the vast majority of MHC
crystallography studies [7,9–11,48–52]. The possibility of such
a scenario is further reduced by the presence of a large
number of ‘‘diluting’’ endogenous or null pMHCs. The lack
of afﬁnity between MHC molecules may not be relevant, if
TCRs exist as dimers on the T cell and ‘‘recruit’’ two pMHC
monomers sequentially. Whether TCRs are present as dimers
on the T cell surface, however, is highly controversial [53–58].
Even if TCRs were dimers, the fast dissociation rate of
agonist pMHC-TCR binding under force (discussed below)
would make it very difﬁcult to successfully recruit the second
agonist pMHC molecule, especially when the number of
agonist pMHCs is low. Finally, the shape of the T cell dose
response curve further supports the sufﬁciency of mono-
meric pMHC for triggering. T cells responded to increasing
numbers of IEk-MCC on the bilayer or on ﬁxed surfaces in a
sublinear fashion, as opposed to a second order dependence
(y ¼ ax
2) that would have indicated a requirement for IEk-
MCC dimers (Figure 6). The sublinear response is consistent
with the wide dynamic range observed in T cell responses to
IEk-MCC on both lipid bilayers and plastic surfaces, and may
indicate a progressive suppression of T cell sensitivity to
increasing doses of agonist pMHCs. The physiological
signiﬁcance of this phenomenon remains to be investigated,
but similar responses have been observed in other biological
systems, such as the response of rod cells to photons
triggering the photoreceptor, rhodopsin [59]. In summary,
our data indicate that individual agonist pMHC monomers
are sufﬁcient to trigger TCR.
In a recent study [29], help from endogenous pMHCs was
used to explain the remarkable T cell sensitivity to agonist
pMHCs on real APCs. A pseudodimer model was proposed in
which an endogenous pMHC engaging TCR could be bridged
by CD4 to form a ‘‘pseudodimer’’ with an agonist pMHC
engaging another TCR [29]. This model of TCR triggering was
based upon experimental data showing that the very low TCR
triggering capacity of agonist pMHC alone (requiring a
density of more than 1,000 per cell on lipid bilayers) [29,60]
Figure 6. T Cells Respond to Agonist pMHC in a Sublinear Fashion
AD10 T cell calcium responses to IEk-MCC diluted by IEk-HSP70 on lipid
bilayers in Figure 2B and AD10 T cell IL2 responses to bio-IEk-MCC on
streptavidin plates in Figure 3A are plotted as power functions of the
calculated number of IEk-MCC per cell. T cell responses are shown as the
ratio of responding to nonresponding cells. Also shown are theoretical
curves of linear and second-degree function responses.
doi:10.1371/journal.pbio.0060043.g006
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presence of endogenous pMHCs. Our observation that one
to ten agonist IEk-MCC alone triggered not only TCR-
induced calcium ﬂux, but also IL2 production, calls into
question the purported requirement for help by endogenous
pMHC. Indeed, using mouse T cells with a transgenic TCR of
the same speciﬁcity, endogenous IEk-ER60 and null IEk-99A,
which were shown to enhance TCR triggering by IEk-MCC in
the previous report, did not, in our hands, enhance TCR
triggering by IEk-MCC on ﬂuid lipid bilayers or ﬁxed plastic
surfaces. As evidenced by our analyses using circular
dichroism and peptide pulsing experiments, the lack of help
by IEk-ER60 could not be attributed to incorrect protein
folding or lack of peptide in the binding groove (Figure S2B–
S2D). IEk-99A differs from IEk-MCC by only one residue, and
the correctness of its tertiary structure is supported by the
fact that tetrameric IEk-99A weakly binds T cells from AND
TCR transgenic mice [35] and acts as a weak agonist for these
T cells (Figure S10 and S. M. Hedrick, personal communica-
tion). The lack of help for TCR triggering by endogenous
pMHC was further supported by our observation that biasing
the endogenous peptide population on real APCs with ER60
or b2m peptides did not affect T cell activation by MCC
peptides. This discrepancy may be partially explained by the
different methodologies used in these studies. We consis-
tently used MHC molecules with covalently linked peptides
expressed in insect cells. In the previous report, both MHC
with covalently linked peptides and empty MHC loaded with
synthetic peptides were used, sometimes in the same experi-
ment. The relative MHC occupancies by the different
peptides were not determined. The differing results of T cell
activation by real cells pulsed with peptides may be due to the
fact that two totally different cell types were used in the two
studies: previously, CHO cells expressing empty GPI-anch-
ored IEk versus, in our study, CH27 B cells expressing IEk, as
well as the appropriate adhesion and costimulatory molecules
of real APCs. Again, in the previous study, the relative level of
different peptides on the surface of CHO cells was not
determined.
Theoretically, some aspects of the pseudodimer model of
TCR remain to be reconciled with what has been learned
regarding TCR triggering and pMHC-TCR interaction. The
hypothesis that CD4 bridges the pseudodimer is not well
supported by experimental data. Coreceptors bind MHC with
very limited afﬁnity and stability and with a fast off-rate [61].
In addition, CD4 has been shown to associate with TCR/CD3
via Lck and ZAP-70 in response to CD3 stimulation [62], but
not on resting T cells. Another issue is that the role of
endogenous pMHC is not clearly explained in the pseudo-
dimer model. Intuitively, it seems that recruitment of free
TCR-CD4 to an agonist pMHC-TCR binding pair would be
easier than recruitment of the TCR-CD4 complex bound to
endogenous pMHC anchored on an opposing membrane. The
resulting complex should function equally well as a pseudo-
dimer. Finally, using TAP-deﬁcient cells, previous reports
demonstrated that endogenous pMHCs had a negligible effect
on the activation by agonist pMHCs of CD8
þ T cells, which
express the same TCR/CD3 complex [24,63].
What is it, then, that transforms a nonfunctional soluble
monomeric agonist pMHC in solution into a powerful TCR
triggering unit once it is attached to a surface? Recent data
suggest that the mechanism of TCR triggering must include
features unique to 2D binding. These include the need for
two opposing membranes to reach the conﬁnement length
for association of membrane-anchored ligands and receptors,
especially ones with small dimensions such as TCR and pMHC
[31,32,64]. What has been omitted, however, is that a bound
ligand–receptor pair, including pMHC-TCR, is constantly
stressed and may be ruptured by forces from the active
cytoskeletal rearrangement that supports the dynamic en-
gagement between T cells and APCs. Recent in vivo studies
using two-photon microscopy have characterized the inter-
action between T cells and antigen-loaded APCs in lymph
nodes during the ﬁrst 2 h as serial and dynamic, with T cells
engaging and disengaging APCs at a speed of 5.4 lm/min
[65,66]. T cells move with a velocity of 2.6 lm/min even at
later stages of dynamic T cell/APC clustering. In this context,
a single speciﬁc interaction between a TCR and an agonist
pMHC may not be able to maintain the small, close
membrane–membrane contact zone and keep tyrosine
kinases and phosphatases segregated, as proposed in the
kinetic-segregation model [30–32]. We demonstrate, in this
study, that TCR triggering requires not only T cell adhesion
to a surface, but also a functional actin cytoskeleton,
consistent with the possibility that detaching forces are
important in TCR triggering.
Here, taking into consideration the dynamic aspect of the
2D interaction between T cells and APCs, especially its likely
impact on the dissociation of pMHC-TCR, we propose the
receptor deformation model of TCR triggering (Figure 7). In
this model, when a T cell encounters and scans an APC,
pMHC and TCR interact when and where a sufﬁciently close
membrane–membrane contact is formed. pMHC-TCR inter-
action per se, however, does not trigger TCR. A signal is
initiated when the binding pair is pulled by a detaching force
originating from cytoskeletal rearrangement, a force origi-
nally intended to detach the membrane–membrane contact
for T cell movement. The pulling force induces a conforma-
tional change of the ab TCR, which is then transferred to the
intracellular domains of the CD3 complex through inter-
actions between their extracellular domains and transmem-
brane domains [67]. Alternatively, it may directly cause
changes in the relative positioning and orientation of the
components of the TCR/CD3 complex. This pulling force
may also induce conformational changes of the coreceptor
binding domains of MHC molecules, and lead to better
recruitment or conformational change of the coreceptors.
The signal is initiated by increased access to and phosphor-
ylation of ITAM domains of the CD3 complex by the
coreceptor-associated tyrosine kinase, Lck. Therefore, the
critical factor that determines whether a particular pMHC-
TCR binding can lead to signaling is whether the binding has
sufﬁcient mechanical strength and appropriate kinetics to
deliver an external force to TCR or pMHC to induce a
conformational change, rather than the afﬁnity, kinetics, or
conformational change under zero force, as proposed in
previous models.
The receptor deformation model provides a solution to the
problem of how the binding between TCRs and pMHCs, both
of which have hugely variable binding interfaces, leads to a
uniform signal initiating conformational change of the TCR/
CD3 complex. It also explains how T cells can detect an
extremely low number of agonist pMHCs, alone, anchored on
surfaces, as we observed in this study. Although under zero
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TCR pairs has been reported to be more than 10 s, and as
long as 50 s for strong agonists [68], it could be much shorter
under a pulling force, because the dissociate rate (koff)
increases exponentially with force [69]. Together, with the
locomotion and dynamic morphological changes of the T
cells, and the active lateral movement of TCR and pMHC on
the ﬂuid membranes [70], a fast dissociation could allow rapid
triggering of multiple neighboring TCRs by a single agonist
pMHC in a short period of time, leading to efﬁcient temporal
and spatial accumulation and integration of multiple signals,
as previously proposed by the serial engagement model [71].
Furthermore, the receptor deformation model offers the
‘‘rupture force’’ of pMHC-TCR binding (the force needed to
rupture the binding) as the mechanism by which T cells
distinguish structurally similar agonist and endogenous
pMHCs. This is supported by the excellent correlation found
between rupture force and the zero force koff [72], which is
correlated with TCR triggering by pMHC [68]. It is intriguing
to speculate that weak rupture forces between TCR and
endogenous pMHC may support minor changes of the TCR/
CD3 complex and generate survival signals. Finally, this
model is consistent with experimental evidence that cognate
pMHC-TCR interaction induces a conformational change in
the CD3 complex [73,74]. Also, force-induced conformational
change has been documented in other ligand-receptor
systems, such as the conformational change of LFA-1 a
domain [75] and Escherichia coli adhesin FimH [76] in response
to shear forces.
The receptor deformation model is very different from a
previously proposed raft-TCR collision model that also
involves force, in which the movement of lipid rafts on T
cells driven by actin or shear stress promotes collision of raft-
associated Lck and the TCR/CD3 complex [77]. This model
works through increased kinase-TCR proximity, rather than
conformational change. In the raft-TCR collision model, the
force is applied laterally on the lipid raft and does not impact
the binding kinetics of pMHC-TCR interaction. Our model is
also distinct from the permissive geometry model, which
proposes that TCRs are present as oligomeric clusters on T
cells, and that binding of multimeric agonist pMHCs with a
certain permissive geometry triggers TCRs through changes
in the relative positioning of individual TCRs within the
cluster [57,78]. The key differences are that changes in TCR
geometry are induced solely by pMHC-TCR interaction,
without the requirement of external mechanical force, and
that multimeric pMHCs are required for triggering.
Notwithstanding its uniqueness and advantages, the re-
Figure 7. The Receptor Deformation Model of TCR Triggering
(A) Interaction of pMHC and TCRs at the membrane–membrane contact site of the T cell/APC interface facilitated by adhesion molecules. The
interaction between agonist pMHC and TCR per se does not initiate TCR signaling.
(B) Forces generated from the cytoskeleton, which drive T cell morphological changes and active T cell movement relative to the APC, detach the T cell
plasma membrane from the APC. Part of this force is delivered to the TCR/CD3 complex via pMHC-TCR binding. Binding between agonist pMHC and
TCR is strong enough to deliver a force that deforms the TCR/CD3 complex to a conformation capable of initiating an activation signal. Weak binding
between TCR and self pMHC breaks before such a force can be delivered. This binding could, however, deliver a weak force that causes minor receptor
deformation, leading to a survival signal. The detaching force might also deform the MHC molecule to a conformation that binds coreceptors with
higher affinity.
doi:10.1371/journal.pbio.0060043.g007
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well-documented observation that soluble multimeric agonist
pMHCs trigger TCR [22,79]. In our opinion, the fact that T
cells can be activated via a receptor crosslinking mechanism
used by B cells is not surprising, given their similarity in
evolution, development, antigen receptor structure, and
intracellular signaling pathways. Our work does not exclude
the possibility that when agonist pMHCs are present at
extremely high levels on APCs, TCR crosslinking is a
functional mechanism of TCR triggering. In this situation,
t h ec h a n c eo ft w on e i g h b o r i n gM H Cm o l e c u l e s ,b o t h
presenting agonist peptides, may be reasonably high. This,
and the fact that a high proportion of MHC molecules on the
APC surface is immobile [26,27], make it plausible that two
monomeric agonist pMHCs might be stably localized in close
enough proximity to act as functional dimers capable of
crosslinking TCRs. Given the rarity of agonist pMHCs on
APCs under physiological conditions, however, a mechanism
that does not rely on TCR crosslinking, such as receptor
deformation, is likely to be the main working mechanism of
TCR triggering.
In conclusion, we provide strong evidence that extremely
small numbers (,10 per cell) of surface-anchored agonist
pMHCs trigger TCR, independent of endogenous pMHCs,
but dependent upon adhesion and intact cytoskeletal
function. We propose the receptor deformation model, in
which cytoskeletal rearrangement delivers the driving force
for TCR triggering. Given its merits in providing a
straightforward mechanism of TCR triggering and in explain-
ing both the high sensitivity and the high speciﬁcity of agonist
pMHC detection by T cells, we believe that this model
warrants further investigation.
Materials and Methods
Mice, chemicals, constructs, and antibodies. B10.BR H-2
k mice and
5C.C7 mice were purchased from Jackson Laboratories and Taconic,
respectively. AD10 and AND TCR transgenic mice were provided by J.
W. Kappler (National Jewish Medical and Research Center). T cell
blasts were generated by a mixed culture of splenocytes from TCR
transgenic mice and B10.BR mice in Click’s medium supplemented
with 10% fetal calf serum (FCS), 2 mM L-glutamine, 50 lM b-
mercaptoethanol, penicillin/streptomycin, 1 mM sodium pyruvate, 0.1
mM nonessential amino acids, and 50 lg/ml pigeon cytochrome c. T
cell blasts were used on day 7 to day 9 poststimulation. POPC, DOPE-
biotin, DOPE-NBD, and DOGS-NTA were purchased from Avanti
Polar Lipids; 14-4-4s mAb was generated from a hybridoma kindly
provided by J. W. Kappler. Anti-ICAM-1 monoclonal antibody,
YN1.7.4, was produced from a hybridoma obtained from ATCC.
Anti-leucine zipper antibody, 2H11, was produced from a hybridoma
from E. L. Reinherz (Dana-Farber Cancer Institute). Streptavidin was
from Sigma. APC-labeled anti-mouse IL2 antibody, JES6-5H4, and
APC-labeled anti-mouse IL4 antibody, 11H11, were from BD
Biosciences. The D10.IL2 T cell line, CH27, and M12.C3 B cell
lymphoma cells were provided by A. Kupfer (Johns Hopkins
University), J. Monroe (University of Pennsylvania), and S. Ostrand-
Rosenberg (University of Maryland), respectively. ER60-bio, b2m-bio,
ER60scrbl-bio (APPNIKYFLSFGTK), and MCC-FITC peptides were
synthesized by Genemed Synthesis. Baculovirus transfer vector,
pBlueBac4.5/V5-His, Sf9, and Hi5 insect cells were purchased from
Invitrogen.
Protein expression and puriﬁcation. All proteins were expressed in
secreted form by infecting Hi5 insect cells with baculovirus.
Baculovirus transfer vector for ICAM-1-AviTag-HisTag was con-
structed with pBlueBac4.5/V5-His and murine ICAM-1 cDNA
ampliﬁed from mouse spleen mRNA. Transfer vectors for IEk-MCC,
IEk-HSP70, IEk-ER60, IEk-99A, and IAk-CA with AviTag and HisTag
were constructed based on a transfer vector for IEk-MCC-AviTag (a
gift from J. W. Kappler). cDNA encoding IAk-CA stabilized with a
leucine zipper was provided by E. L. Reinherz. ICAM-1, IEk, and IAk
proteins were afﬁnity puriﬁed with columns conjugated with NTA-Ni,
14-4-4s antibody, and 2H11 antibody, respectively. Each protein was
then further puriﬁed by gel ﬁltration with a Superdex 200 10/300 GL
column (Amersham Biosciences) before storage. IEk-MCC was kept at
4 8C for less than 10 d and was never frozen and thawed. An
additional round of gel ﬁltration was always performed immediately
before use of the proteins in experiments. IEk-MCC and ICAM-1 were
biotinylated with BIRA enzyme (Avidity) and puriﬁed by gel ﬁltration.
The biotinylation rate was about 50%, as measured by an ELISA-
based assay. To generate (IEk-MCC)-SA, bio-IEk-MCC and streptavi-
din were mixed at a 1:5 molar ratio, and monovalent complexes were
puriﬁed by two successive rounds of gel ﬁltration with a Superdex 200
10/300 GL column. To generate (ICAM-1)2-SA, bio-ICAM-1 and
streptavidin were mixed at a 1:1 molar ratio, and bivalent complexes
were puriﬁed by gel ﬁltration. Puriﬁed complexes were used
immediately without storage.
Lipid bilayer preparation. Liposomes were prepared by sonication
using POPC mixed with 0.2 mol% DOPE-NBD and 5 mol% DOGS-
NTA or DOPE-biotin in HEPES-Na buffer (150 mM NaCl, 5 mM
HEPES [pH 7.4] with 0.02% sodium azide). The liposome solution was
then spun at 40,000 rpm for 2 h, and small unilamellar vesicles (SUV)
were isolated by taking the top four-ﬁfths of the solution. Supported
planer lipid bilayers were prepared by liposome fusion for 10 min at
4 8C on glass cover slips that had been extensively cleaned with
Contrad70 detergent (Decon Laboratories) and chromic sulfuric acid
solution (Sigma). Half of the lipid bilayer was collapsed by exposure
to air before transferring to 25 8C for 40 min for expansion. Lipid
bilayers were then transferred under HEPES-Na buffer into FCS2
ﬂow chambers (Bioptechs) for imaging. For bilayer containing DOGS-
NTA, HEPES-Na buffer containing 0.25 mM NiSO4 was introduced
into the chamber for 10 min to charge DOGS-NTA with Ni
2þ.
Lipid bilayer-based artiﬁcial APC preparation. Lipid bilayers were
blocked with blocking buffer (5 mg/ml BSA in HEPES-Na buffer [pH
7.4]) for 10 min. For lipid bilayers with DOGS-NTA, 10 lg/ml IEk and
1 lg/ml ICAM-1 in blocking buffer were introduced into the chamber
and incubated for 30 min at 25 8C. The bilayer was then washed with
imaging buffer (150 mM NaCl, 5 mM KCl, 2 mg/ml glucose, 10 mM
HEPES [pH 7.4], 33 mg/ml BSA) containing 1 mM CaCl2 and 1 mM
MgCl2 for 3 min under constant buffer ﬂow. For bilayers with DOPE-
biotin, the blocked bilayer was incubated with 1 lg/ml (IEk-MCC)-SA
ﬁrst, followed by 5 lg/ml (ICAM-1)2-SA in imaging buffer. The bilayer
was then washed with imaging buffer containing 0.25 mM MnCl2 and
0.25 mM CaCl2.
Determination of IEk ligand density on lipid bilayers. For POPC
bilayers with 5 mol% DOGS-NTA, IEk-MCC was labeled with FITC.
For POPC bilayers with 5 mol% DOPE-biotin, biotinylated IEk-MCC
was labeled with FITC and was used to form the (FITC-IEk-MCC)-SA
complex. After binding of the FITC-labeled proteins, the bilayers
were lysed with 200 ll of DPBS (pH 7.4) containing 1% Triton-X100
and 0.5 mg/ml BSA. The intensity of FITC was read using a high
numerical aperture (0.5) 103air objective (Zeiss) and recorded with a
12-bit cooled CCD camera. POPC bilayer without DOGS-NTA or
DOPE-bio was used as a blank control. After subtracting the FITC
intensity of the blank, the FITC intensity was translated into protein
concentration based on a standard curve generated using FITC-
labeled proteins of known concentration. The ligand densities were
calculated based on the amount of protein bound and the area of the
lipid bilayer.
Microscopy and image analysis For calcium imaging, 5 3 10
6 TCR
transgenic CD4
þ T cells were pulsed with 5 lMf u r a - 2 - A M
(Invitrogen) for 30 min at room temperature and washed twice with
imaging buffer before introduction into the ﬂow chamber. The 510-
nm emissions excited by 380 nm and 340 nm were captured at 5-s
intervals for 30 min using a 403 oil Plan-Neoﬂuar objective on an
Axioplan2 Microscope (Zeiss) at 25 8C. Data were collected and
analyzed with SlideBook software (Intelligent Imaging Innovations).
Nomarski DIC bright-ﬁeld imaging with a 603 water Achroplan
objective was used to capture cell adhesion on the lipid bilayer and to
measure the T cell diameter. For FRAP, a pattern of 4-lm radius was
photobleached with a 3 mW nitrogen laser (Stanford Research
Systems), and the recovery was captured using an attenuated xenon
light source (Sutter).
T cell stimulation on plates and intracellular IL2 staining. Bio-IEk-
MCC in PBS pH 8.0 was coated on Immulon2 U-bottom ELISA plates
(Thermo Electron) or SigmaScreen streptavidin-coated plates (Sigma;
binding capacity  6 pmol biotin/well) for 18 h at 4 8Co r3 78C,
respectively. For experiments requiring saturation of the plate by
another coating protein, 10 lg/ml nonbiotinylated or biotinylated
proteins were subsequently added to ELISA or streptavidin plates in a
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then incubated at room temperature for 4 h or 1 h, respectively.
Plates were washed, and 2.5 3 10
5 T cells were added in complete
Click’s medium containing 20 lg/ml brefeldin A. After 7 h incubation,
cells were harvested, ﬁxed with 3% formaldehyde in PBS, permea-
bilized with PBS buffer containing 1% BSA and 0.1% saponin, and
stained with anti-IL2 mAb for ﬂow cytometric analysis.
Pulsing of CH27 cells with peptides. CH27 cells at 5310
5/ml were
incubated with 1 mM b2m-bio, ER60-bio, or Er60srcbl-bio peptides in
Click’s medium with 10 mM HEPES for 20 h at 37 8C. After washing
three times with Click’s medium, cells were incubated for 30 min at
37 8C with MCC-FITC peptides at different dilutions. After washing,
half of the cells pulsed at each dilution were then stained with
streptavidin-Cy5, and the FITC and Cy5 intensities were measured by
ﬂow cytometry. The other half of the cells were incubated with AD10
T cells at a 1:1 ratio for assay of IL2 production.
Supporting Information
Figure S1. Long-Range Free Diffusion of Glass-Supported Lipid
Bilayers and Anchored Proteins
(A) Fluorescence recovery of a photobleached area on the POPC/
1mol% DOPE-NBD bilayer.
(B) Recovery of a photobleached area on the POPC bilayer containing
5mol% DOGS-NTA-Ni with bound FITC-labeled IEk-MCC.
(C) Recovery of a photobleached area on the POPC bilayer
containing 5mol% DOPE-biotin with bound FITC-labeled streptavi-
din. The bilayer itself was not ﬂuorescently labeled in (B) and (C). The
scale bar represents 10 lm.
Found at doi:10.1371/journal.pbio.0060043.sg001 (1.2 MB DOC).
Figure S2. Characterization of the Puriﬁed IEk Proteins with
Covalently Linked Peptides Expressed and Secreted by Insect Cells
(A) FPLC gel ﬁltration chromatography of IEk-MCC and BSA. A
single peak corresponding to IEk-MCC monomer was observed. Only
fractions from the center of the peak were collected for anchoring
onto the lipid bilayer. As a comparison, the chromatography of
similar-sized BSA shows naturally occurring dimers and multimers.
The percentages of BSA monomers, dimmers, and multimers were
calculated based on the areas of the peaks.
(B) Circular dichroism spectra of puriﬁed IEk-MCC, IEk-ER60, and
IEk-HSP70 proteins (300 lg/ml) at 25 8C. Data were acquired using a
0.1-cm cuvette on a J-810 CD spectropolarimeter (JASCO) with 0.2-
nm steps and 2-s integration times. Each spectrum is the average of
three scans.
(C) Thermal melt of IEk proteins monitored at 208 nm. Temperature
was increased at 2 8C intervals with 100-s equilibration times for each
temperature point. Each melting curve is the average of three melts.
The higher melting temperature than previously reported for IEk
with bound peptide and the ‘‘kink’’ in the middle of melting curve
may be attributed to the fact that all peptides in this study are
covalently linked to IEk. The covalent linkage may enhance
stabilization of the a-helical structure, which forms the IEk peptide-
binding groove, by bound peptides.
(D) Bio-IEk-ER60 and bio-IEk-HSP70 cannot be loaded with MCC
peptides. Bio-IEk-ER60 and bio-IEk-HSP70 proteins were incubated
with 50 lM MCC peptides in PBS-citric acid buffer (pH 5.3) at 37 8C
for 18 h on streptavidin-coated plates. The plates were then washed
and AD10 T cells were added in medium containing 20 lg/ml
brefeldin A. IL2 production was measured by intracellular staining
after 7 h.
Found at doi:10.1371/journal.pbio.0060043.sg002 (76 KB DOC).
Figure S3. IAk-CA Activates D10 T Cells
ELISA plates coated with 30 lg/ml IAk-CA or BSA were used to
stimulate D10.IL2 T cells in medium containing 20 lg/ml brefeldin A
for 7 h. IL4 production was measured by intracellular staining with
the monoclonal antibody, 11H11, by ﬂow cytometry.
Found at doi:10.1371/journal.pbio.0060043.sg003 (97 KB DOC).
Figure S4. The Level of bio-IEk-MCC Proteins on the ELISA Plates
Used in Figure 3D Was Determined by Binding of SA-HRP
The amount of bound SA-HRP was determined by measuring the
optical density at 415 nm (OD415 nm) from ABTS substrate
colorization.
Found at doi:10.1371/journal.pbio.0060043.sg004 (50 KB DOC).
Figure S5. Determining the Streptavidin Binding Capacity of 14-4-4s-
bio Antibody Using a Gel Filtration Chromatography-Based Assay
Ten micrograms of 14-4-4s-bio (Ab) was mixed with excess amounts
of streptavidin (SA). The gel ﬁltration plot (using the same Superdex
200 10/300 GL column) of the mixture (Ab-SA) was superimposed by
the plots of known amounts of SA and Ab. The amount of SA and the
SA:Ab ratio in the Ab-SA complex was calculated to be 4.67:1, based
on the integrated areas of Ab-SA, Ab, and SA. These data are
representative of two independent experiments.
Found at doi:10.1371/journal.pbio.0060043.sg005 (48 KB DOC).
Figure S6. Measuring the Level of Endogenous Peptides on CH27 and
M12.C3 Cells after Peptide Pulsing
CH27 or M12.C3 cells incubated with 1 mM b2m-bio, ER60-bio, or
ER60scrbl-bio for 20 h were washed and stained with streptavidin-
Cy5. To measure the level of IEk, CH27 cells were stained with IEk-
speciﬁc antibody 14-4-4s-bio followed by streptavidin-Cy5. The
ﬂuorescence intensity of Cy5 was measured by ﬂow cytometry. The
peptide occupancy of IEk was calculated based on Cy5 intensities on
biotinylated peptide-pulsed cells relative to those on cells stained
with antibody 14-4-4s-bio, and the streptavidin binding capacity of
the antibody (as calculated in Figure S5).
Found at doi:10.1371/journal.pbio.0060043.sg006 (192 KB DOC).
Figure S7. Schematics of the Interaction between the T Cell and the
Biotin Lipid Bilayer-Based Artiﬁcial APC
Monovalent (IEk-MCC)-SA and bivalent (ICAM-1)2-SA were gener-
ated and puriﬁed by gel ﬁltration. Lipid bilayers containing 5 mol%
DOPE-biotin were anchored with (IEk-MCC)-SA alone (A) or together
with (ICAM-1)2-SA (B).
Found at doi:10.1371/journal.pbio.0060043.sg007 (87 KB DOC).
Figure S8. Contact of MCC-Pulsed CH27 Cells and AD10 T Cells with
or without Treatment with Cytochalasin D
The green cells are T cells. Images were taken after calcium ﬂux
monitoring, as described in Figure 5C and 5D.
Found at doi:10.1371/journal.pbio.0060043.sg008 (452 KB DOC).
Figure S9. TCR Triggering by Agonist pMHC on Lipid Bilayers and
Plastic Surfaces Requires Intact Actin Cytoskeletal Function
(A and B) Lipid bilayers containing 5 mol% DOGS-NTA-Ni were
incubated with 1 lg/ml IEk-MCC. After washing, the bilayers were
used to stimulate fura-2–pulsed AD10 T cells treated with 10 lM
cytochalasin D for 1 h (B), or untreated T cells (A). Calcium ﬂux was
monitored using a 403 oil objective and displayed in pseudocolor.
(C and D) The 12-well tissue culture plates were coated with 100 lg/ml
streptavidin in PBS (pH 7.4) for 2 h at 37 8C. After washing, the plates
were blocked with PBS (pH 7.4) containing 5 mg/ml BSA for 10 min
and incubated with 1 lg/ml bio-IEk-MCC for 4 h at room temper-
ature. After washing, the plate was used to stimulate fura-2–pulsed
AD10 T cells treated with 10 lM cytochalasin D for 1 h (D), or
untreated T cells (C). Calcium ﬂux was monitored using a 603 water
immersion objective and displayed in pseudocolor.
Found at doi:10.1371/journal.pbio.0060043.sg009 (287 KB DOC).
Figure S10. IEk-99A Is a Weak Agonist for AND TCR Transgenic T
Cells
ELISA plates coated with 10 lg/ml IEk-MCC or IEk-99A were used to
stimulate primed AND T cells in medium containing 20 lg/ml
brefeldin A for 7 h. IL2 production was measured by intracellular
staining and ﬂow cytometry.
Found at doi:10.1371/journal.pbio.0060043.sg010 (27 KB DOC).
Text S1. Possible Reasons for the Difference in Shape and Range of
the Response Curves to IEk on Streptavidin versus ELISA Plates
Found at doi:10.1371/journal.pbio.0060043.sd001 (26 KB DOC).
Text S2. Calculation Based on Poisson Distribution of the Number of
pMHCs That Activated 5% of T Cells on Plastic Plates or Lipid
Bilayers
Found at doi:10.1371/journal.pbio.0060043.sd002 (38 KB DOC).
Video S1. Time-Lapse Video Corresponding to Image in Figure 2A:
IEk-MCC Mixed with GFP-HisTag
NTA-Ni bilayers were anchored with IEk-MCC mixed with GFP-
HisTag at a 1:1,000 ratio. Calcium responses of fura-2–pulsed AD10
CD4
þ T cells were captured at 5-s intervals for 30 min. The level of
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video is 25 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv001 (8.5 MB MOV).
Video S2. Time-Lapse Video Corresponding to Image in Figure 2A:
Control
Only GFP-HisTag was anchored on the NTA-Ni bilayer. Calcium
responses of fura-2–pulsed AD10 CD4
þ T cells were captured at 5-s
intervals for 30 min. The level of intracellular calcium is displayed in
pseudocolor. The speed of the video is 25 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv002 (6 MB MOV).
Video S3. Time-Lapse Video Corresponding to Image in Figure 2A:
IEk-MCC Mixed with IEk-ER60
NTA-Ni bilayers were anchored with IEk-MCC mixed with IEk-ER60
at a 1:1,000 ratio. Calcium responses of fura-2–pulsed AD10 CD4
þ T
cells were captured at 5-s intervals for 30 min. The level of
intracellular calcium is displayed in pseudocolor. The speed of the
video is 25 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv003 (4.6 MB MOV).
Video S4. Time-Lapse Video Corresponding to Image in Figure 2A:
IEk-MCC Mixed with IEk-HSP70
NTA-Ni bilayers were anchored with IEk-MCC mixed with IEk-HSP70
at a 1:1,000 ratio. Calcium responses of fura-2–pulsed AD10 CD4
þ T
cells were captured at 5-s intervals for 30 min. The level of
intracellular calcium is displayed in pseudocolor. The speed of the
video is 25 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv004 (3.6 MB MOV).
Video S5. T cells Adhere to Bilayers with Anchored ICAM-1
POPC bilayers with 5 mol% DOPE-biotin, with anchored (ICAM-1)2-
SA, were tilted at a very small angle so that, without adhesion (Video
S6), T cells moved slowly on the surface due to gravity. T cells were
imaged in buffer containing 0.25 mM Ca
2þ and 0.25 mM Mn
2þ to
activate LFA-1 and promote adhesion. Movement of T cells was
captured with DIC bright ﬁeld imaging at 5-s intervals. The speed of
the video is 50 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv005 (1.3 MB MOV).
Video S6. T cells Do Not Adhere to Bilayers without Anchored
ICAM-1
POPC bilayers with 5 mol% DOPE-biotin, without anchored (ICAM-
1)2-SA, were tilted at a very small angle so that, without adhesion, T
cells moved slowly on the surface due to gravity. T cells were imaged
in buffer containing 0.25 mM Ca
2þ and 0.25 mM Mn
2þ to activate
LFA-1 and promote adhesion. Movement of T cells was captured with
DIC bright ﬁeld imaging at 5-s intervals. The speed of the video is 50
times real time.
Found at doi:10.1371/journal.pbio.0060043.sv006 (2.7 MB MOV).
Video S7. Time-Lapse Video Corresponding to Figure 5A
Calcium responses of fura-2–pulsed AD10 CD4
þT cells were captured
at 5-s intervals for 10 min. Calcium levels are displayed in pseudo-
color. The speed of the video is 50 times real time. Due to the
quenching effect of Mn
2þin the imaging buffer on the ﬂuorescence of
fura-2, fura-2–pulsed AD10 T cells gradually lost ﬂuorescence
intensity during the course of image capture. Note that the few T
cells with continuously high calcium levels are dead cells.
Found at doi:10.1371/journal.pbio.0060043.sv007 (1.2 MB MOV).
Video S8. Time-Lapse Video Corresponding to Figure 5B
Calcium responses of fura-2–pulsed AD10 CD4
þT cells were captured
at 5-s intervals for 10 min. Calcium levels are displayed in pseudo-
color. The speed of the video is 50 times real time. Due to the
quenching effect of Mn
2þin the imaging buffer on the ﬂuorescence of
fura-2, fura-2–pulsed AD10 T cells gradually lost ﬂuorescence
intensity during the course of image capture. Note that the few T
cells with continuously high calcium levels are dead cells.
Found at doi:10.1371/journal.pbio.0060043.sv008 (1 MB MOV).
Video S9. Cytochalasin D Treatment of T Cells Blocks Calcium Flux
Induced by CH27 Cells Pulsed with MCC: Results for Untreated
Cells
A layer of CH27 cells pulsed for 1 h with 1 lM MCC-FITC was
attached on cover glasses coated with poly-L-lysine. Fura-2 AM–
pulsed untreated AD10 T cells were introduced, and calcium ﬂux was
monitored. Calcium levels are displayed in pseudocolor. The speed of
the video is 50 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv009 (3.9 MB MOV).
Video S10. Cytochalasin D Treatment of T Cells Blocks Calcium Flux
Induced by CH27 Cells Pulsed with MCC
A layer of CH27 cells pulsed for 1 h with 1 lM MCC-FITC were
attached on cover glasses coated with poly-L-lysine. AD10 T cells
treated for 1 h with 10 lM cytochalasin D were introduced, and
calcium ﬂux was monitored. Calcium levels are displayed in pseudo-
color. The speed of the video is 50 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv010 (5 MB MOV).
Video S11. Cytochalasin D Treatment Does Not Affect Calcium Flux
Stimulated by Antibody Crosslinking: Results of Untreated Cells
Untreated AD10 T cells were attached on poly-L-lysine–coated cover
glasses in a ﬂow chamber; 10 lg/ml biotinylated anti-Vb3 monoclonal
antibody, KJ25, was introduced and incubated for 10 min. A few T
cells ﬂuxed calcium at low levels during incubation. The antibody was
then washed away, and 10 lg/ml streptavidin was introduced.
Crosslinking by streptavidin led to high-level calcium ﬂux in most
of the cells (the last quarter of the video). Calcium levels are displayed
in pseudocolor. The speed of the video is 50 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv011 (5.7 MB MOV).
Video S12. Cytochalasin D Treatment Does Not Affect Calcium Flux
Stimulated by Antibody Crosslinking
AD10 T cells treated with 10 lM cytochalasin D for 1 h at 37 8C were
attached on poly-L-lysine–coated cover glasses in a ﬂow chamber; 10
lg/ml biotinylated anti-Vb3 monoclonal antibody, KJ25, was intro-
duced and incubated for 10 min. A few T cells ﬂuxed calcium at low
levels during incubation. The antibody was then washed away, and 10
lg/ml streptavidin was introduced. Crosslinking by streptavidin led to
high-level calcium ﬂux in most of the cells (the last quarter of the
video). Calcium levels are displayed in pseudocolor. The speed of the
video is 50 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv012 (5.1 MB MOV).
Video S13. Cytochalasin D Treatment Does Not Affect Calcium Flux
Stimulated by Antibody Crosslinking: Results of Cytochalasin D
Introduced Together with Streptavidin
Untreated AD10 T cells were attached on poly-L-lysine–coated cover
glasses in a ﬂow chamber. The untreated AD10 T cells were incubated
with KJ25 antibody ﬁrst, then 10 lg/ml streptavidin was introduced
together with 10 lM cytochalasin D. A few T cells ﬂuxed calcium at
low levels during incubation. Crosslinking by streptavidin led to high-
level calcium ﬂux in most of the cells (the last quarter of the video).
Calcium levels are displayed in pseudocolor. The speed of the video is
50 times real time.
Found at doi:10.1371/journal.pbio.0060043.sv013 (6.7 MB MOV).
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